Fund Holdings — Boxer Capital Management, LLC

Total Portfolio Value:
$198.66M
Total Bought:
$51.71M
Total Sold:
$260.60M
Net Transaction:
-$208.89M
Notable People:
Aaron Isaac Davis
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Tango Therapeutics, Inc.(TNGX)10,380,9999,771,485-609,514$14.22M$50.03M25.18%+$35.81M
Revolution Medicines, Inc.(RVMD)1,317,977792,977-525,000$46.60M$29.17M14.69%-$17.43M
Replimune Group, Inc.(REPL)1,796,3412,211,341+415,000$17.51M$20.54M10.34%+$3.03M
Merus N V700,000365,000-335,000$29.46M$19.20M9.66%-$10.26M
Kymera Therapeutics, Inc.(KYMR)325,000432,010+107,010$8.90M$18.85M9.49%+$9.96M
uniQure N.V.SHS(QURE)750,000899,500+149,500$7.95M$12.54M6.31%+$4.59M
Iteos Therapeutics Inc0825,000+825,000$0$8.23M4.14%+$8.23M
UroGen Pharma Ltd.(URGN)0575,000+575,000$0$7.88M3.97%+$7.88M
Amylyx Pharmaceuticals, Inc.(AMLX)1,750,0001,225,000-525,000$6.20M$7.85M3.95%+$1.66M
Crescent Biopharma, Inc.(CBIO)0453,686+453,686$0$7.32M3.69%+$7.32M
Protagonist Therapeutics Inc060,000+60,000$0$3.32M1.67%+$3.32M
Nektar Therapeutics(NKTR)0125,000+125,000$0$3.23M1.63%+$3.23M
Kodiak Sciences Inc.(KOD)1,035,000750,000-285,000$2.91M$2.80M1.41%-$110.8K
Cidara Therapeutics Inc055,000+55,000$0$2.68M1.35%+$2.68M
Nurix Therapeutics, Inc.(NRIX)563,067175,000-388,067$6.69M$1.99M1.00%-$4.70M
Instil Bio, Inc.(TIL)80,12570,700-9,425$1.39M$1.47M0.74%+$81.7K
Kalvista Pharmaceuticals Inc093,400+93,400$0$1.06M0.53%+$1.06M
Sarepta Therapeutics, Inc.(SRPT)025,000+25,000$0$427.5K0.22%+$427.5K
Nuvation Bio Inc.W EXP 02 10 202(NUVB)266,666266,6660$85.3K$72.0K0.04%-$13.4K
Surrozen, Inc.W EXP 08 01 203(SRZN)66,66666,6660$2.0K$1.2K0.00%-$793
Nuvalent Inc450,0000-450,000$31.91M$0—-$31.91M
Avidity Biosciences Inc865,0000-865,000$25.53M$0—-$25.53M
Anaptysbio Inc1,300,0000-1,300,000$24.17M$0—-$24.17M
Xenon Pharmaceuticals Inc.(XENE)600,0000-600,000$20.13M$0—-$20.13M
Apellis Pharmaceuticals Inc
COM
713,0000-713,000$15.59M$0—-$15.59M
Chimerix Inc1,810,0000-1,810,000$15.40M$0—-$15.40M
Enliven Therapeutics Inc671,3580-671,358$13.21M$0—-$13.21M
ORIC Pharmaceuticals, Inc.(ORIC)1,732,5710-1,732,571$9.67M$0—-$9.67M
Day One Biopharmaceuticals I
COM
1,189,9430-1,189,943$9.44M$0—-$9.44M
Prothena Corp PlcSHS
SHS
690,0000-690,000$8.54M$0—-$8.54M
Legend Biotech CorporationADS(LEGN)200,0000-200,000$6.79M$0—-$6.79M
Solid Biosciences Inc1,240,7000-1,240,700$4.59M$0—-$4.59M
Denali Therapeutics Inc.(DNLI)250,0000-250,000$3.40M$0—-$3.40M
Prelude Therapeutics Incorporated(PRLD)2,108,0140-2,108,014$1.62M$0—-$1.62M
Boundless Bio, Inc.(BOLD)250,0000-250,000$377.5K$0—-$377.5K
Climb Bio, Inc.(CLYM)145,0000-145,000$176.9K$0—-$176.9K
Page 1 of 1
Boxer Capital Management, LLC — 13F Holdings — Q2 2025 | TickerTrail